Results 151 to 160 of about 42,337 (292)

Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation. [PDF]

, 1998
Okamoto
openalex   +2 more sources

Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes. [PDF]

Ann Hematol
Galli N, Pettine L, Croci G, Passamonti F, Barcellini W, Fattizzo B.   +5 more
europepmc   +1 more source

Apoptosis in bone marrow of myelodysplastic syndrome patients [letter; comment] [PDF]

, 1996
Andrija Bogdanović, GM Jankovic, M Čolović, DP Trpinac, VZ Bumbasirevic   +4 more
openalex   +1 more source

VEXAS Syndrome and Substance Use Disorders: A Large‐Scale, Propensity‐Matched, Case‐Control Analysis Revealing Immune‐Mediated Comorbidities

International Journal of Dermatology, EarlyView.
Kritin K. Verma, Kevin T. Nguyen, Daniel P. Friedmann, Helen Chen, Michelle B. Tarbox   +4 more
wiley   +1 more source

Use of a Foamy‐Virus Vector System to Produce an ‘Off‐the‐Shelf’ Fcγ‐CR‐T Cell Product for the Treatment of Haematological and Solid Tumour Malignancies

Immunology, EarlyView.
Despite the huge success of chimeric antigen receptor (CAR)‐T cells in the treatment of hematologic malignancies, safety concerns have recently been raised in terms of tumorigenesis, relating to the viral vector systems used for product generation, underlying the need for alternative methods for gene modification.
Ioanna Lazana, Emmanouil Simantirakis, Evangelos Kourous, Maria Daniil, Dimitris Ioannou, George Vassilopoulos   +5 more
wiley   +1 more source

Restoration of Autophagy and Apoptosis in Myelodysplastic Syndromes: The Effect of Azacitidine in Disease Pathogenesis. [PDF]

Curr Issues Mol Biol
Tsekoura G, Agathangelidis A, Kontandreopoulou CN, Fasouli ES, Katsantoni E, Pliaka V, Alexopoulos L, Katana E, Papaioannou M, Taktikou G, Strataki ME, Taliouraki A, Mantzourani M, Viniou NA, Diamantopoulos PT, Kollia P.   +15 more
europepmc   +1 more source

Use of human recombinant erythropoietin and prednisone for treatment of myelodysplastic syndrome with erythroid predominance in a dog [PDF]

, 1998
Laura Boone, Kenneth W. Knauer, Steve W. Rapp, Jerry F. Stewart, Jaime F. Modiano   +4 more
openalex   +1 more source

Endothelial Activation Stress Index predicts all‐cause and cardiovascular mortality in patients with diabetes: A nationwide study

Journal of Diabetes Investigation, EarlyView.
Elevated Endothelial Activation and Stress Index (EASIX) is independently associated with increased all‐cause and cardiovascular mortality in patients with diabetes. ABSTRACT Introduction Evidence suggests that the Endothelial Activation and Stress Index (EASIX) predicts mortality in endothelium‐related conditions, but its link to mortality risk in ...
Gaiying Dong, Tingting Wu, Xiaofan Gu, Yuyi Feng, Liangliang Wu, Zhiwen Hu   +5 more
wiley   +1 more source

Treatment of lower-risk myelodysplastic syndromes. [PDF]

Haematologica
Merz AMA, Platzbecker U.
europepmc   +1 more source

1 Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes [PDF]

, 1996
Georgine E. de Greef, Anne Hagemeijer
openalex   +1 more source